Abstract
Epidemiological data of phytoestrogens and prostate cancer strongly supports the cancer protective effects of isoflavones found in soy products. Inhibition of cell proliferation via hormone-dependent and hormone-independent mechanisms by soy phytochemicals has been studied extensively in cell culture and animal studies. Herein, we review the current literature on the epidemiology and effects of two soy phytoestrogens, genistein and daidzein, and would stress the need for controlled human trials to assess the true preventive and therapeutic effects of these compounds.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 71-81 |
| Number of pages | 11 |
| Journal | Urologic Clinics of North America |
| Volume | 29 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 17 2002 |
ASJC Scopus subject areas
- Urology
Fingerprint Dive into the research topics of 'The role of soy phytoestrogens in prostate cancer'. Together they form a unique fingerprint.
Cite this
Castle, E. P., & Thrasher, J. B. (2002). The role of soy phytoestrogens in prostate cancer. Urologic Clinics of North America, 29(1), 71-81. https://doi.org/10.1016/S0094-0143(02)00019-8